Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 892579, 10 pages
http://dx.doi.org/10.1155/2015/892579
Research Article

Association of Environmental Arsenic Exposure, Genetic Polymorphisms of Susceptible Genes, and Skin Cancers in Taiwan

1Genomics Research Center, Academia Sinica, No. 128 Academia Road, Section 2, Nankang, Taipei 115, Taiwan
2Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei 100, Taiwan
3School of Public Health, College of Public Health and Nutrition, Taipei Medical University, 250 Wu-Hsing Street, Taipei 110, Taiwan
4Department of Medical Research, Shuang Ho Hospital, Taipei Medical University, No. 291 Zhongzheng Road, Zhonghe District, New Taipei City 23561, Taiwan
5Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, 250 Wu-Hsing Street, Taipei 110, Taiwan
6Molecular and Genomic Epidemiology Center, China Medical University Hospital, China Medical University, Taichung 404, Taiwan
7Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, 17 Xu-Zhou Road, Taipei 100, Taiwan

Received 26 August 2014; Revised 12 March 2015; Accepted 19 March 2015

Academic Editor: Marian K. Malde

Copyright © 2015 Ling-I Hsu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. O. Abernathy, D. J. Thomas, and R. L. Calderon, “Health effects and risk assessment of arsenic,” Journal of Nutrition, vol. 133, pp. 1536S–1538S, 2003. View at Google Scholar · View at Scopus
  2. H.-Y. Chiou, Y.-M. Hsueh, K.-F. Liaw et al., “Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan,” Cancer Research, vol. 55, no. 6, pp. 1296–1300, 1995. View at Google Scholar · View at Scopus
  3. K. H. Morales, L. Ryan, T.-L. Kuo, M.-M. Wu, and C.-J. Chen, “Risk of internal cancers from arsenic in drinking water,” Environmental Health Perspectives, vol. 108, no. 7, pp. 655–661, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. T. G. Rossman, A. N. Uddin, and F. J. Burns, “Evidence that arsenite acts as a cocarcinogen in skin cancer,” Toxicology and Applied Pharmacology, vol. 198, no. 3, pp. 394–404, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. C.-J. Chen, L.-I. Hsu, C.-H. Wang et al., “Biomarkers of exposure, effect, and susceptibility of arsenic-induced health hazards in Taiwan,” Toxicology and Applied Pharmacology, vol. 206, no. 2, pp. 198–206, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. W. P. Tseng, H. M. Chu, S. W. How, J. M. Fong, C. S. Lin, and S. Yeh, “Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan,” Journal of the National Cancer Institute, vol. 40, no. 3, pp. 453–463, 1968. View at Google Scholar · View at Scopus
  7. K. T. Kitchin and S. Ahmad, “Oxidative stress as a possible mode of action for arsenic carcinogenesis,” Toxicology Letters, vol. 137, no. 1-2, pp. 3–13, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Qian, V. Castranova, and X. Shi, “New perspectives in arsenic-induced cell signal transduction,” Journal of Inorganic Biochemistry, vol. 96, no. 2-3, pp. 271–278, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. K. T. Kitchin, “Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites,” Toxicology and Applied Pharmacology, vol. 172, no. 3, pp. 249–261, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. M.-M. Wu, H.-Y. Chiou, T.-C. Lee et al., “GT-repeat polymorphism in the heme oxygenase-1 gene promoter and the risk of carotid atherosclerosis related to arsenic exposure,” Journal of Biomedical Science, vol. 17, no. 1, article 70, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. M. M. Wu, H. Y. Chiou, C. L. Chen et al., “GT-repeat polymorphism in the heme oxygenase-1 gene promoter is associated with cardiovascular mortality risk in an arsenic-exposed population in northeastern Taiwan,” Toxicology and Applied Pharmacology, vol. 248, no. 3, pp. 226–233, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Zhang, F. F. Song, Y. B. Huang, H. Zheng, F. J. Song, and K. X. Chen, “Association between the (GT)n polymorphism of the HO-1 gene promoter region and cancer risk: a meta-analysis,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 11, pp. 4617–4622, 2014. View at Google Scholar
  13. B. Lajin and A. Alachkar, “The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis,” British Journal of Cancer, vol. 109, no. 5, pp. 1325–1337, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Hassett, L. Aicher, J. S. Sidhu, and C. J. Omiecinski, “Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants,” Human Molecular Genetics, vol. 3, no. 3, pp. 421–428, 1994. View at Publisher · View at Google Scholar
  15. J. Han, S. E. Hankinson, G. A. Colditz, and D. J. Hunter, “Genetic variation in XRCC1, sun exposure, and risk of skin cancer,” British Journal of Cancer, vol. 91, no. 8, pp. 1604–1609, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. H. H. Nelson, K. T. Kelsey, L. A. Mott, and M. R. Karagas, “The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-environment interaction,” Cancer Research, vol. 62, no. 1, pp. 152–155, 2002. View at Google Scholar · View at Scopus
  17. H. Zhang, W. Li, M. J. Franklin, and A. Z. Dudek, “Polymorphisms in DNA repair gene XRCC1 and skin cancer risk: a meta-analysis,” Anticancer Research, vol. 31, no. 11, pp. 3945–3952, 2011. View at Google Scholar · View at Scopus
  18. A. Bravard, M. Vacher, E. Moritz et al., “Oxidation status of human OGG1-S326C polymorphic variant determines cellular DNA repair capacity,” Cancer Research, vol. 69, no. 8, pp. 3642–3649, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Le Marchand, T. Donlon, A. Lum-Jones, A. Seifried, and L. R. Wilkens, “Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk,” Cancer Epidemiology Biomarkers and Prevention, vol. 11, no. 4, pp. 409–412, 2002. View at Google Scholar · View at Scopus
  20. D. Y. Xing, W. Tan, N. Song, and D. X. Lin, “Ser326Cys polymorphism in hOGG1 gene and risk of esophageal cancer in a Chinese population,” International Journal of Cancer, vol. 95, no. 3, pp. 140–143, 2001. View at Publisher · View at Google Scholar
  21. L. Ma, H. Chu, M. Wang et al., “hOGG1 Ser326Cys polymorphism is associated with risk of bladder cancer in a Chinese population: a case-control study,” Cancer Science, vol. 103, no. 7, pp. 1215–1220, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Coin, J.-C. Marinoni, C. Rodolfo, S. Fribourg, A. M. Pedrini, and J.-M. Egly, “Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH,” Nature Genetics, vol. 20, no. 2, pp. 184–188, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. U. Vogel, A. Olsen, H. Wallin, K. Overvad, A. Tjønneland, and B. A. Nexø, “Effect of polymorphisms in XPD, RAI, ASE-1 and ERCC1 on the risk of basal cell carcinoma among Caucasians after age 50,” Cancer Detection and Prevention, vol. 29, no. 3, pp. 209–214, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Lovatt, J. Alldersea, J. T. Lear et al., “Polymorphism in the nuclear excision repair gene ERCC2/XPD: association between an exon 6-exon 10 haplotype and susceptibility to cutaneous basal cell carcinoma,” Human Mutation, vol. 25, no. 4, pp. 353–359, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. K. M. Appelbaum, M. R. Karagas, D. J. Hunter et al., “Polymorphisms in nucleotide excision repair genes, arsenic exposure, and non-melanoma skin cancer in New Hampshire,” Environmental Health Perspectives, vol. 115, no. 8, pp. 1231–1236, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. Y.-C. Chen, Y.-L. L. Guo, H.-J. J. Su et al., “Arsenic methylation and skin cancer risk in Southwestern Taiwan,” Journal of Occupational and Environmental Medicine, vol. 45, no. 3, pp. 241–248, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. Y.-M. Hsueh, G.-S. Cheng, M.-M. Wu, H.-S. Yu, T.-L. Kuo, and C.-J. Chen, “Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver disease and malnutritional status,” British Journal of Cancer, vol. 71, no. 1, pp. 109–114, 1995. View at Publisher · View at Google Scholar · View at Scopus
  28. Y.-M. Hsueh, H.-Y. Chiou, Y.-L. Huang et al., “Serum β-carotene level, arsenic methylation capability, and incidence of skin cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 6, no. 8, pp. 589–596, 1997. View at Google Scholar · View at Scopus
  29. R. C. Yu, K.-H. Hsu, C.-J. Chen, and J. R. Froines, “Arsenic methylation capacity and skin cancer,” Cancer Epidemiology Biomarkers & Prevention, vol. 9, no. 11, pp. 1259–1262, 2000. View at Google Scholar · View at Scopus
  30. C. H. Sierra-Torres, W. W. Au, C. D. Arrastia et al., “Polymorphisms for chemical metabolizing genes and risk for cervical neoplasia,” Environmental and Molecular Mutagenesis, vol. 41, no. 1, pp. 69–76, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. S. L. Cheng, C. J. Yu, C. J. Chen, and P. C. Yang, “Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD,” European Respiratory Journal, vol. 23, no. 6, pp. 818–824, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Sanyal, F. Festa, S. Sakano et al., “Polymorphisms in DNA repair and metabolic genes in bladder cancer,” Carcinogenesis, vol. 25, no. 5, pp. 729–734, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Lin, Y.-M. Hsueh, J.-L. Ko, Y.-F. Liang, K.-J. Tsai, and C.-Y. Chen, “Analysis of NQO1, GSTP1, and MnSOD genetic polymorphisms on lung cancer risk in Taiwan,” Lung Cancer, vol. 40, no. 2, pp. 123–129, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Stoehlmacher, D. J. Park, W. Zhang et al., “A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer,” British Journal of Cancer, vol. 91, no. 2, pp. 344–354, 2004. View at Google Scholar · View at Scopus
  35. S.-J. Park, H. Zhao, M. R. Spitz, H. B. Grossman, and X. Wu, “An association between NQO1 genetic polymorphism and risk of bladder cancer,” Mutation Research, vol. 536, no. 1-2, pp. 131–137, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Zhang, W. A. Schulz, Y. Li et al., “Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population,” Carcinogenesis, vol. 24, no. 5, pp. 905–909, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Gsur, T. Zidek, K. Schnattinger et al., “Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk,” British Journal of Cancer, vol. 89, no. 4, pp. 702–706, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Korhonen, E.-L. Romppanen, M. Hiltunen et al., “Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are associated with polycystic ovary syndrome,” Fertility and Sterility, vol. 79, no. 6, pp. 1353–1357, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. K.-W. Chang, T.-C. Lee, W.-I. Yeh et al., “Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers,” British Journal of Cancer, vol. 91, no. 8, pp. 1551–1555, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. E. J. Duell, R. C. Millikan, G. S. Pittman et al., “Polymorphisms in the DNA repair gene XRCC1 and breast cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 10, no. 3, pp. 217–222, 2001. View at Google Scholar · View at Scopus
  41. M. Dybdahl, U. Vogel, G. Frentz, H. Wallin, and B. A. Nexø, “Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma,” Cancer Epidemiology Biomarkers and Prevention, vol. 8, no. 1, pp. 77–81, 1999. View at Google Scholar · View at Scopus
  42. H. Sugimura, T. Kohno, K. Wakai et al., “hOGG1 Ser326Cys polymorphism and lung cancer susceptibility,” Cancer Epidemiology Biomarkers and Prevention, vol. 8, no. 8, pp. 669–674, 1999. View at Google Scholar · View at Scopus
  43. H. Wikman, A. Risch, F. Klimek et al., “hOGG1 polymorphism and loss of heterozygosity (LOH): significance for lung cancer susceptibility in a caucasian population,” International Journal of Cancer, vol. 88, no. 6, pp. 932–937, 2000. View at Publisher · View at Google Scholar